Inventor
GUDKOV ANDREI V
US29 patents
⚠️ This page may combine multiple inventors who share the name “GUDKOV ANDREI V”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CLEVELAND CLINIC FOUND
8 patentsUS10086038B2Oct 2, 2018
Flagellin related polypeptides and uses thereof
CLEVELAND CLINIC FOUND2 citations83
US9827289B2Nov 28, 2017
Flagellin related polypeptides and uses thereof
CLEVELAND CLINIC FOUND3 citations83
US9457061B2Oct 4, 2016
Flagellin related polypeptides and uses thereof
CLEVELAND CLINIC FOUND4 citations83
US11235028B2Feb 1, 2022
Protection against stress-mediated damage from ionizing radiation
CLEVELAND CLINIC FOUND0 citations62
US10898543B2Jan 26, 2021
Flagellin related polypeptides and uses thereof
CLEVELAND CLINIC FOUND0 citations62
US10406206B2Sep 10, 2019
Protection against stress-mediated damage from ionizing radiation
CLEVELAND CLINIC FOUND0 citations52
US9585939B2Mar 7, 2017
Protection against apoptosis from ionizing radiation
CLEVELAND CLINIC FOUND0 citations52
US10543251B2Jan 28, 2020
Flagellin related polypeptides and uses thereof
CLEVELAND CLINIC FOUND0 citations51
GUDKOV ANDREI V
7 patentsUS8287882B2Oct 16, 2012
Flagellin related polypeptides and uses thereof
GUDKOV ANDREI V29 citations95
US8106005B2Jan 31, 2012
Modulating apoptosis
GUDKOV ANDREI V30 citations95
US8580321B2Nov 12, 2013
Method for reducing the effects of chemotherapy using flagellin related polypeptides
GUDKOV ANDREI V24 citations91
US8784840B2Jul 22, 2014
Method for screening modulators of apoptosis
GUDKOV ANDREI V5 citations83
US9205095B2Dec 8, 2015
Viral vector encoding a toll-like receptor and encoding a toll-like receptor agonist
GUDKOV ANDREI V4 citations72
US8242057B2Aug 14, 2012
Methods for identifying modulators of apoptosis
GUDKOV ANDREI V2 citations62
US8932609B2Jan 13, 2015
Flagellin related polypeptides and uses thereof
GUDKOV ANDREI V0 citations51
CLEVELAND CLINIC FOUNDATION
5 patentsUS8007812B2Aug 30, 2011
Flagellin related polypeptides and uses thereof
CLEVELAND CLINIC FOUNDATION29 citations95
US8871215B2Oct 28, 2014
Flagellin related polypeptides and uses thereof
CLEVELAND CLINIC FOUNDATION9 citations92
US9139623B2Sep 22, 2015
Flagellin related polypeptides and uses thereof
CLEVELAND CLINIC FOUNDATION1 citations62
US9296793B2Mar 29, 2016
Modulating apoptosis
CLEVELAND CLINIC FOUNDATION0 citations52
US9228000B1Jan 5, 2016
Flagellin related polypeptides and uses thereof
CLEVELAND CLINIC FOUNDATION0 citations51
UNIV ILLINOIS
4 patentsUS6982277B2Jan 3, 2006
P53 inhibitors and therapeutic use of the same
UNIV ILLINOIS51 citations94
US6593353B1Jul 15, 2003
p53 inhibitors and therapeutic use of the same
UNIV ILLINOIS36 citations94
US7012087B2Mar 14, 2006
p53 inhibitors and therapeutic use of the same
UNIV ILLINOIS17 citations90
US7008956B2Mar 7, 2006
p53 inhibitors and therapeutic use of the same
UNIV ILLINOIS16 citations90
GENOME PROT INC
4 patentsUS10336793B2Jul 2, 2019
Flagellin-based agents and uses including effective vaccination
GENOME PROT INC6 citations83
US10730915B2Aug 4, 2020
Flagellin-based agents and uses including effective vaccination
GENOME PROT INC2 citations72
US11542306B2Jan 3, 2023
Flagellin-based agents and uses including effective vaccination
GENOME PROT INC0 citations62
US10975127B2Apr 13, 2021
Flagellin-based agents and uses including effective vaccination
GENOME PROT INC0 citations62